Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
8.12
+0.02 (0.25%)
Oct 28, 2026, 4:00 PM EDT - Market closed
Grifols Market Cap
Grifols has a market cap or net worth of $7.15 billion as of October 28, 2026. Its market cap has increased by 9.96% in one year.
Market Cap
7.15B
Enterprise Value
19.69B
1-Year Change
9.96%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since June 2, 2011, Grifols's market cap has increased from $5.00B to $7.15B, an increase of 43.15%. That is a compound annual growth rate of 2.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 5.57B | -13.37% |
| Dec 31, 2025 | 6.43B | 25.67% |
| Dec 31, 2024 | 5.12B | -35.64% |
| Dec 29, 2023 | 7.95B | 36.00% |
| Dec 30, 2022 | 5.84B | -24.31% |
| Dec 31, 2021 | 7.72B | -39.10% |
| Dec 31, 2020 | 12.68B | -20.82% |
| Dec 31, 2019 | 16.01B | 26.85% |
| Dec 31, 2018 | 12.62B | -19.90% |
| Dec 29, 2017 | 15.76B | 42.63% |
| Dec 30, 2016 | 11.05B | -0.80% |
| Dec 31, 2015 | 11.14B | -4.68% |
| Dec 31, 2014 | 11.69B | -0.94% |
| Dec 31, 2013 | 11.80B | 39.30% |
| Dec 31, 2012 | 8.47B | 134.45% |
| Dec 30, 2011 | 3.61B | -27.71% |
| Jun 2, 2011 | 5.00B | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 264.64B |
| Amgen | 242.18B |
| Gilead Sciences | 197.25B |
| Novo Nordisk | 171.10B |
| Pfizer | 169.85B |
| Bristol-Myers Squibb Company | 125.73B |
| GSK plc | 102.56B |
| Sanofi | 100.32B |